Back

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs

European Heart Journal

2 April 2025
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE
You may be interested in
thumbnail
Congress Presentation
Glycoprotein VI inhibition
30 August 2024
thumbnail
Webinar
ESC guidelines on acute pulmonary embolism - practical guidance into clinical practice. Part 1: Acute phase - diagnosis and risk adjusted management
8 February 2021
thumbnail
Congress Presentation
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
1 September 2020
thumbnail
Congress Presentation
Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources